Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A strong welfare state mitigates the impact of the Great Recession

  • Costs to treat bleeding strokes increases 10 years later

  • For brain hemorrhage, risk of death lower at high-volume hospitals

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  •